Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Current Pharmaceutical Design|March 29, 2024
Cellular and Mitochondrial Pathways Contribute to SGLT2 Inhibitors-mediated Tissue Protection: Experimental and Clinical DataRaúl Lelio Sanz, Sebastián García Menéndez, Felipe Inserra, et al.
Current Drug Targets|July 4, 2019
Current Drug Nano-targeting Strategies for Improvement in the Diagnosis and Treatment of Prevalent Pathologies such as Cardiovascular and Renal DiseasesVirna Margarita Martín Giménez, Lucía Beatriz Fuentes, Diego Enrique Kassuha, et al.
Journal of Hypertension|December 18, 2009
Caveolin-1 and Hsp70 interaction in microdissected proximal tubules from spontaneously hypertensive rats as an effect of LosartanVictoria Bocanegra, Walter Manucha, Marcelo Rodríguez Peña, et al.
Therapeutic Advances in Cardiovascular Disease|December 7, 2020
Differences in RAAS/vitamin D linked to genetics and socioeconomic factors could explain the higher mortality rate in African Americans with COVID-19Virna Margarita Martín Giménez, León Ferder, Felipe Inserra, et al.
World Journal of Experimental Medicine|March 26, 2026
Renin-angiotensin system blockade attenuates brain mitochondrial dysfunction, oxidative stress, and neuroinflammation associated with hypertension, metabolic disorders, and agingSebastián García Menéndez, Felipe Inserra, Elena Mv de Cavanagh, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|July 29, 2020
Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infectionJosé Luis Mansur, Carlos Tajer, Javier Mariani, et al.
Biotechnology Progress|December 15, 2018
Preparation and characterization of bosentan monohydrate/ε-polycaprolactone nanoparticles obtained by electrosprayingVirna M Giménez, Norma Sperandeo, Sonia Faudone, et al.
Current Hypertension Reports|February 25, 2017
Role of Mitochondrial Dysfunction in Hypertension and ObesityVicente Lahera, Natalia de Las Heras, Antonio López-Farré, et al.
Pediatric Nephrology (Berlin, Germany)|October 5, 2011
Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndromePatricia G Vallés, Silvia Melechuck, Adriana González, et al.
Pageof 11